Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMountview Est. Regulatory News (MTVW)

Share Price Information for Mountview Est. (MTVW)

Share Price is delayed by 15 minutes
Get Live Data
9,000.00    0.00 (0.00%)
Bid:
8,800.00
Ask:
9,000.00
Spread: 200.00 (2.273%)
Market Cap: £350.91m
MTVW Live PriceLast checked at - London Stock Exchange

Intraday Mountview Est. Share Chart

Half Yearly Report

28 Nov 2013 07:00

RNS Number : 1311U
Mountview Estates PLC
28 November 2013
 



Embargoed 07.00a.m 28 November 2013

Mountview Estates P.L.C.

Interim Results

 

MOUNTVIEW ESTATES P.L.C.

 

UNAUDITED INTERIM RESULTS FOR THE HALF YEAR ENDED 30 SEPTEMBER 2013

 

OUR PERFORMANCE

 

Turnover at £28.8 million up by 11.2% (2012 - £25.9m)

 

Gross profit at £15.9 million up by 3.2% (2012 - £15.4m)

 

Profit before tax at £13.2 million up by 10.9% (2012 - £11.9m)

 

Earnings per share at 275.5 pence up by 12.3% (2012 - 245.4p)

 

Net assets per share at £64.10 up by 7.4% (2012 - £59.71)

 

DIVIDEND INFORMATION

 

Mountview Estates P.L.C. advises its shareholders that, following the issue of the interim results, the relevant dates in respect of the interim dividend payment of 50p per share are as follows:

 

Ex-dividend date 19 February 2014

Record date 21 February 2014

Payment date 31 March 2014

 

C.E.O.'s STATEMENT

 

The interim dividend of 50 pence per share (2012: 50p) in respect of the year ended 31 March 2014 is payable on 31 March 2014 to shareholders on the Register of Members as at 21 February 2014. These half year figures clearly show steady progress but the Board will not consider any increase in the dividend until they have the results for the full year.

 

Purchases totalling over £20 million have been made during these six months. All the properties are located in London and the South East. Net assets have shown steady growth. Borrowings have risen during the six months, but are lower than they were a year ago. Gearing has been kept at a modest level.

 

We have relied upon our long established modus operandi which is carried out by experienced management. Our conservative policies continue to produce reliable results and our recent recruits are proving their worth and establishing themselves as potential future senior management.

 

We are well equipped to take further purchasing opportunities and look to the future with confidence.

 

GROUP STATEMENT OF COMPREHENSIVE INCOME (UNAUDITED)

for the half year ended 30 September 2013

 

 

Half year ended 30.09.2013

£000

Half year

ended

30.09.2012

£000

Year

ended 31.03.2013

£000

Revenue

28,825

25,901

56,646

Cost of Sales

(12,931)

(10,530)

(22,906)

Gross Profit

15,894

15,371

33,740

Administrative expenses

(1,721)

(1,488)

(3,759)

Gain/(Loss) on sale of investment properties

264

(11)

84

Operating profit before changes in

fair value of investment properties

14,437

13,872

30,065

Increase in fair value of investment properties

-

-

2,602

 

Profit from operations

14,437

13,872

32,667

 

Change in fair value of derivatives

-

210

563

Net finance costs

(1,191)

(2,190)

(4,302)

Profit before taxation

13,246

11,892

28,928

 

Taxation - current

(3,312)

(2,804)

(6,511)

Taxation - deferred

807

482

(272)

 

Taxation

(2,505)

(2,322)

(6,783)

 

Profit attributable to equity Shareholders

10,741

9,570

22,145

 

Basic and diluted earnings per share (pence)

275.5p

245.4p

568.0p

 

 

 

 

All items within the consolidated income statement relate to continuing operations.

 

 

 

 

 

 

 

 

 

GROUP STATEMENT OF FINANCIAL POSITION (UNAUDITED)

for the half year ended 30 September 2013

 

 

As at

As at

As at

30.09.2013

30.09.2012

31.03.2013

£000

£000

£000

Assets

Non-current assets

Property, plant and equipment

2,238

2,375

2,337

Investment properties

26,373

26,517

27,852

28,611

28,892

30,189

Current assets

Inventories of trading properties

328,034

316,431

316,626

Trade and other receivables

1,080

1,160

1,198

Cash and cash equivalents

1,147

1,691

900

330,261

319,282

318,724

 

Total assets

358,872

348,174

348,913

 

Equity and liabilities

 

Capital and reserves attributable

to equity holders of the Company

 

Share capital

195

195

195

Capital redemption reserve

55

55

55

Capital reserve

25

25

25

Other reserves

56

56

56

Cash flow hedge reserve

-

(520)

-

Retained earnings

249,509

233,015

243,641

 

 

249,840

232,826

243,972

Non-current liabilities

Long-term borrowings

92,250

92,700

84,950

Deferred tax

5,487

5,541

6,294

97,737

98,241

91,244

Current liabilities

Bank overdrafts and loans

7,074

12,454

8,427

Trade and other payables

948

980

1,631

Current tax payable

3,273

2,801

3,639

Derivative financial instruments

-

872

-

 

11,295

17,107

13,697

 

Total liabilities

109,032

115,348

104,941

 

Total equity and liabilities

358,872

348,174

348,913

 

 

 

 

 

 

 

 

 

GROUP CASHFLOW STATEMENT (UNAUDITED)

for the half year ended 30 September 2013

 

 

 

Half year

Half year

Year

ended

ended

ended

30.09.2013

30.09.2012

31.03.2013

£000

£000

£000

Cash flows from operating activities

Profit from operations

14,437

13,872

32,667

Adjustment for:

Depreciation

52

86

163

Loss on disposal of property, plant and equipment

16

-

3

(Gain)/Loss on disposal of investment properties

(264)

11

(84)

(Increase) in fair value of investment properties

-

-

(2,602)

Operating cash flows before movement

in working capital

14,241

13,969

30,147

(Increase) in inventories

(11,408)

(15,359)

(15,554)

Decrease in receivables

118

211

173

(Decrease)/Increase in payables

(683)

(405)

246

Cash generated from operations

2,268

(1,584)

15,012

 

Interest paid

(1,191)

(2,190)

(4,302)

Income taxes paid

(3,665)

(2,782)

(5,675)

Net cash (outflow) from operating activities

 

(2,588)

 

(6,556)

 

5,035

 

Investing activities

Proceeds from disposal of investment properties

2,018

59

1,939

Capital expenditure on investment properties

Purchase of property, plant and equipment

(275)

-

(50)

(55)

(567)

(74)

Proceeds from disposal of property, plant and equipment

18

-

-

Net cash inflow/(outflow) from investing activities

1,761

(46)

1,298

 

Cash flows from financing activities

 

Increase in borrowings

7,300

2,750

687

Repayment of borrowings

(587)

-

(5,050)

Equity dividend paid

(4,873)

(4,483)

(6,432)

Net cash inflow/(outflow) from financing activities

1,840

(1,733)

(10,795)

 

Net increase/(decrease) in cash and cash equivalents

1,013

(8,335)

(4,462)

 

Opening cash and cash equivalents

(6,565)

(2,103)

(2,103)

Cash and cash equivalents at end of period

(5,552)

(10,438)

(6,565)

 

 

 

 

 

GROUP CONSOLIDATED STATEMENT OF CHANGES IN EQUITY

for the half year ended 30 September 2013

 

 

 

 

Half year

Half year

Year

ended

ended

ended

30.09.2013

30.09.2012

31.03.2013

£000

£000

£000

Shareholders' funds as at the beginning of the period

 

243,972

 

227,219

 

227,219

Reduction in reserve

-

520

1,040

 

Profit for the period

10,741

9,570

22,145

Dividends

(4,873)

(4,483)

(6,432)

Shareholders' funds at the end of the period

249,840

232,826

243,972

 

 

~ Ends ~

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR GBBDBUGDBGXI
Date   Source Headline
26th May 202610:27 amRNSUpdate on General Meeting voting outcome
20th Apr 202611:00 amRNSHolding(s) in Company
20th Apr 202610:59 amRNSHolding(s) in Company
20th Apr 202610:58 amRNSHolding(s) in Company
31st Mar 202611:05 amRNSDirector/PDMR Shareholding
30th Mar 20266:30 pmRNSDividend Payment Delay
25th Mar 20265:04 pmRNSDirector/PDMR Shareholding
25th Mar 202610:01 amRNSDirector/PDMR Shareholding
19th Mar 202610:02 amRNSDirector/PDMR Shareholding
18th Mar 202612:29 pmRNSDirector/PDMR Shareholding
25th Feb 20264:21 pmRNSDirector/PDMR Shareholding
23rd Feb 202612:49 pmRNSDirector/PDMR Shareholding
12th Feb 202612:03 pmRNSDirector/PDMR Shareholding
10th Feb 20264:28 pmRNSDirector/PDMR Shareholding
9th Feb 202611:16 amRNSDirector/PDMR Shareholding
26th Jan 20263:38 pmRNSBoard Committee change
22nd Dec 202511:40 amRNSDirector/PDMR Shareholding
22nd Dec 202511:40 amRNSDirector/PDMR Shareholding
20th Nov 20257:00 amRNSUnaudited Interim Results for 6m ended 30 Sep 2025
17th Nov 202512:15 pmRNSResult of General Meeting
22nd Oct 202512:00 pmRNSNotice of General Meeting
17th Oct 202512:22 pmRNSDirector/PDMR Shareholding
16th Oct 20251:04 pmRNSDirector/PDMR Shareholding
15th Oct 20254:29 pmRNSDirector/PDMR Shareholding
1st Oct 20251:16 pmRNSDirector/PDMR Shareholding
15th Aug 20257:03 amRNSBoard changes
13th Aug 20251:46 pmRNSResult of Annual General Meeting
30th Jul 20255:10 pmRNS2025 Annual Report and Accounts
24th Jul 202512:32 pmRNSDirector/PDMR Shareholding
22nd Jul 20251:05 pmRNSDirector/PDMR Shareholding
17th Jul 20255:20 pmRNSDirector/PDMR Shareholding
11th Jul 202511:22 amRNSPublication of 2025 Annual Report & Notice of AGM
19th Jun 20257:00 amRNSPreliminary Results: year ended 31 March 2025
16th May 20257:00 amRNSUpdate on General Meeting voting outcome
31st Mar 20257:00 amRNSDirectorate change – Contract Extension
26th Mar 202512:02 pmRNSDirector/PDMR Shareholdings
28th Feb 20255:25 pmRNSDirector/PDMR Shareholding
14th Feb 20257:00 amRNSUpdate on 2024 Annual General Meeting outcome
21st Nov 20242:09 pmRNSDirector/PDMR Shareholding
20th Nov 20247:00 amRNSUnaudited Interim Results for 6m ended 30 Sep 2024
19th Nov 20249:59 amRNSDirectorate Change
18th Nov 202412:07 pmRNSResult of General Meeting
23rd Oct 202412:00 pmRNSNotice of General Meeting
19th Sep 20246:11 pmRNSDirector/PDMR Shareholding
14th Aug 20241:37 pmRNSResult of Annual General Meeting
23rd Jul 20248:58 amRNSPublication of 2024 Annual Report and Accounts
12th Jul 20249:31 amRNSAnnual Financial Report and Notice of AGM
20th Jun 20247:00 amRNSPreliminary Results: year ended 31 March 2024
20th May 20247:00 amRNSUpdate on General Meeting voting outcome
14th Mar 20242:04 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.